Boniva ad hyped efficacy: DDMAC
February 15 2011
A print ad for Genentech's Boniva overstated the osteoporosis drug's efficacy, said the FDA's DDMAC in an untitled letter.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.